Company intelligence / Profile preview

Agencourt Bioscience

Beverly, Massachusetts, United Statesftc.gov ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Agencourt Bioscience was a leading provider of genomic services and nucleic acid purification products. Its SPRI magnetic bead-based technology became widely adopted in genome research, including sequencing over one-third of the human genome. The company was one of five Large Scale Sequencing Centers funded by the National Human Genome Research Institute. It did not develop therapeutics but enabled genomics research.

Modalities: Nucleic acid purification technology
Industry: Molecular Diagnostics

Partnerships

National Human Genome Research Institute/NIH

Beyond the preview

Go deeper on Agencourt Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agencourt Bioscience.

Explore the full profile